FIELD: biotechnology; medicine.
SUBSTANCE: invention relates to biotechnology and medicine. The method for assessing the primary response to the combined chemotherapy before treatment is proposed, for which polymorphic alleles of АРОЕ - ɛ2, АРОЕ - ɛ3, АРОЕ - ɛ4 are detected.
EFFECT: method makes it possible to quickly obtain a noninvasively significant criterion for assessing the prognosis of the risk of developing a negative response to combined CT for patients with sporadic advanced ovarian cancer, which is a useful addition to the diagnostic complex for screening patients in the preoperative period and individualizes the approach to the treatment of patients with ovarian cancer.
1 cl, 4 dwg, 10 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CYTOREDUCTIVE SURGERY VOLUME IN PATIENTS WITH ADVANCED OVARIAN CANCER AFTER COMPLETION OF THIRD COURSE OF NEOADJUVANT CHEMOTHERAPY | 2017 |
|
RU2671409C2 |
| METHOD FOR PREDICTION OF NEOADJUVANT CHEMOTHERAPY EFFECTIVENESS IN PATIENTS WITH DISSEMINATED FORMS OF OVARIAN CANCER | 2017 |
|
RU2637410C1 |
| METHOD FOR DETERMINING THE EFFECTIVENESS OF CHEMOTHERAPY WITH PLATINUM PREPARATIONS IN III-IV STAGE OVARIAN CANCER | 2020 |
|
RU2738167C1 |
| METHOD FOR PREDICTION OF PROBABILITY OF POSSIBLE EXECUTION OF OPTIMUM CYTOREDUCTIVE OPERATION IN PATIENTS WITH DISSEMINATED FORMS OF OVARIAN CANCER | 2017 |
|
RU2637399C1 |
| METHOD FOR PREDICTING DURATION OF DISEASE-FREE INTERVAL AFTER COMPLETION OF PRIMARY TREATMENT OF PATIENTS WITH OVARY CANCER | 2018 |
|
RU2676702C2 |
| METHOD FOR PREDICTING RECURRENCE OF SEROUS OVARIAN CARCINOMA | 2020 |
|
RU2749361C1 |
| METHOD FOR PREDICTING THE OUTCOME OF OVARIAN CANCER FOLLOWING ADJUVANT CHEMOTHERAPY ACCORDING TO THE AP | 2018 |
|
RU2699561C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF IRON DEFICIENCY IN PATIENTS WITH OVARIAN CANCER | 2023 |
|
RU2800104C2 |
| METHOD FOR PREDICTION OF CISPLATIN TREATMENT EFFICACY IN MALIGNANT DISEASE | 2014 |
|
RU2582968C2 |
| METHOD FOR THE TREATMENT OF PERITONEAL CARCINOMATOSIS IN OVARIAN CANCER | 2021 |
|
RU2745478C1 |
